Maria Cherska: Exploring the Role of Fucoidan in Metabolic Liver Disease
Maria Cherska, The head of cardiology department at The State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism», shared a post on LinkedIn about a recent article by Xueru Chu et al., published in Lipids in Health and Disease։
“NAFLD/MASLD remains one of the most important cardiometabolic challenges worldwide – and this publication nicely highlights the role of oxidative stress and inflammation in disease progression.
A very interesting study recently published in Lipids in Health and Disease, demonstrated that fucoidan reduced lipid accumulation, oxidative stress, and NF-κB-mediated inflammation in a 3D NAFLD spheroid model through regulation of the PI3K/AKT/Nrf2 signaling pathway.
Particularly interesting:
- use of an advanced 3D spheroid NAFLD model;
- focus on oxidative stress and inflammatory pathways;
- potential future role of nutraceutical and functional food approaches in metabolic medicine.
Great to see this kind of translational and mechanistic research published in Lipids in Health and Disease – an important journal in the field of lipid metabolism, cardiometabolic diseases, and preventive medicine.”
Title: Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model
Authors: Xueru Chu, Xuan Wang, Keqing Feng, Yanzhen Bi, Yongning Xi, Shousheng Liu
Stay updated with Hemostasis Today.
-
Oct 6, 2026, 22:43Alessandra Bosch: Pediatric GTH Opens with Regional Experts Convening on Pediatric Hemostasis and Thrombosis
-
Oct 6, 2026, 22:39Managing Thrombotic Risk in Pregnancy: How the Lab May Help – Sysmex Europe
-
Oct 6, 2026, 22:33Ahmet Davut Aksu: A Multi-Objective Approach to Enhance Fibrinolysis, Selectivity, and Inhibition Resistance
-
Oct 6, 2026, 22:29Muhammad Abubakar: New Study on Iron Biology to Be Presented at ASH 2026 and Published in Blood
-
Oct 6, 2026, 22:24David McIntosh: Calling On Decision-Makers to Prioritize Donors and Clinical Access During IPAW 2026
-
Oct 6, 2026, 22:21Zoltan Nagy: With All Eyes on Optogenetics Today, What Can It Do in Megakaryocytes and Platelets?
-
Oct 6, 2026, 22:13Khalid A. Fakhro: Sidra Medicine Hosts RAPID 2026 Advancing Diagnostics and Treatments for Inborn Errors of Immunity
-
Oct 6, 2026, 22:04Denis Oduor: Preparedness for Postpartum Haemorrhage Must Include Preparedness for Blood
-
Oct 6, 2026, 21:57Farhad Moradpour: Health Equity and Public Health – What Drives Anemia Disparities in Ethnic Minority Populations?